Page last updated: 2024-11-02

pamidronate and Diabetic Neuropathies

pamidronate has been researched along with Diabetic Neuropathies in 2 studies

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naqvi, A1
Cuchacovich, R1
Saketkoo, L1
Espinoza, LR1
Jude, EB1
Selby, PL1
Burgess, J1
Lilleystone, P1
Mawer, EB1
Page, SR1
Donohoe, M1
Foster, AV1
Edmonds, ME1
Boulton, AJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348]Phase 338 participants (Anticipated)Interventional2020-11-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for pamidronate and Diabetic Neuropathies

ArticleYear
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Diabetologia, 2001, Volume: 44, Issue:11

    Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthropathy, Neurogenic; Biomarkers; Bo

2001

Other Studies

1 other study available for pamidronate and Diabetic Neuropathies

ArticleYear
Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
    The American journal of the medical sciences, 2008, Volume: 335, Issue:2

    Topics: Aged, 80 and over; Arthropathy, Neurogenic; Bone Density Conservation Agents; Diabetes Mellitus, Typ

2008